Find, organize, attend, and make the most of Oncology & Hematology events worldwide

OncoSystem Directory

Explore organizations in the global Oncology ecosystem

908 organization(s) found

Innovation Organization

OPALE Carnot Institute

OPALE Carnot Institute is the healthcare industry’s preferred partner for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and most frequent children's cancer.

Paris, France
Website
Company

Orca Bio

At Orca Bio, our mission is to transform the lives of patients through high-precision cell therapy. We are developing allogeneic T-cell immunotherapies for the treatment of high-risk blood cancers including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and myelodysplastic syndrome (MDS). We remain focused on expanding treatment to as many patients who could benefit by advancing our pipeline in blood cancer, autoimmune diseases and beyond.

Allogeneic T-cell immunotherapies
Menlo Park, CA, United States
T-cell TherapiesCell TherapiesAllogeneicBlood CancersHemato-OncologyLeukemiaMDS
Website
Company

Orion Pharma

Orion Pharma is a globally operating Nordic pharmaceutical company � a builder of well-being for over a hundred years. We draw on our century-long experience in healthcare while keeping our sights firmly set on future innovations to support you every step of your way. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others.

Discovery, development and commercialization of new therapies for Oncology, Respiratory Diseases, Neurologic Diseases and other areas
Espoo, Finland
Drug Discovery & DevelopmentCancer TherapeuticsSmall-Molecule DrugsAndrogen Receptor Inhibitors
Website
Company

Orum Therapeutics

Orum Therapeutics, Inc. is a biopharmaceutical company leveraging our proprietary platforms for research and development of new pharmaceuticals for cancer and immune diseases. We are pioneering a class of therapeutics intended to expand the universe of druggable targets and to meaningfully improve upon potency and tolerability, and thereby improve the therapeutic window of drugs. Our goal is to bring life-changing therapies to patients by combining the power of the emerging field of protein degraders with the precision of antibodies to generate a broad portfolio of highly differentiated product candidates.

Targeted protein-degradation conjugates (TPD2) for Oncology
Yuseong-Gu, Daejeon, South Korea
Drug Discovery & DevelopmentCancer TherapeuticsSmall-Molecule DrugsBiologicsmAbsConjugatesADCs
Website
Company

Oryzon Genomics

Biopharmaceutical company that develops epigenetic drugs, including an LSD1 inhibitor studied in acute myeloid leukemia.

Epigenetic Therapies
Barcelona, Spain
EpigeneticsAcute Myeloid LeukemiaDrug Discovery
Website
Hospital

Osaka City University Hospital

Osaka, Japan
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Osaka International Cancer Institute

Osaka, Japan
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Osaka University Hospital

Osaka, Japan
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

OSE Immunotherapeutics

French biotechnology company that develops immunotherapies in oncology and inflammation.

Immunotherapy
Nantes, France
ImmunotherapyImmuno-OncologyBiotechnology
Website
Hospital

Oslo University Hospital

Norwegian university hospital that includes the Norwegian Radium Hospital cancer centre.

University Hospital
Oslo, Norway
Cancer CareHematologyClinical Research
Website
Hospital

Ospedale Borgo Trento

Verona, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Ospedale Policlinico San Matteo

Pavia, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Ospedale San Raffaele - Gruppo San Donato

Milan, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

Otsuka Pharmaceutical

Pharmaceutical company with an oncology portfolio that includes hypomethylating agents for myeloid blood cancers.

Pharmaceuticals
Tokyo, Japan
Myelodysplastic SyndromesAcute Myeloid LeukemiaPharmaceuticals
Website
Company

Outpace Bio

Outpace Bio is building a robust pipeline of engineered T cell therapies with curative potential that leverage Outpace technologies across modalities, targets, and indications.

T-cell therapies (CAR-T, TCR-T) for Oncology
Seattle, WA, United States
Cancer TherapeuticsProtein EngineeringCell TherapyCAR-T TherapyTCR-T TherapySolid Tumors
Website
Company

Owkin

Company that applies artificial intelligence to biomedical data for drug discovery and diagnostics.

AI for Biomedical Research
Paris, France
Artificial IntelligenceDrug DiscoveryDigital PathologyData
Website
Company

Oxford BioTherapeutics

Oxford BioTherapeutics is a clinical-stage oncology company, developing first-in-class antibody-based therapies to improve patient outcomes. Our proprietary, proteomic target discovery platform, OGAP�-Verify, specialises in identifying novel membrane-based protein targets.

ADCs and TCEs for treatment of solid tumors
Oxford, United Kingdom
Drug Discovery & DevelopmentBiologicsConjugatesADCsT-cell EngagersSolid Tumors
Website
University / R&D Center

PACRI (Pan African Cancer Research Institute)

The Pan African Cancer Research Institute (PACRI) is a centre of excellence dedicated to cutting edge integrated translational cancer research, education and clinical care with a vision of accelerating discoveries to prevent and cure cancer in the African region. It is aimed at developing internationally competitive cancer research capabilities in Africa with an emphasis on Afrocentric solutions, enhancing the probability of finding homegrown solutions for the cancer challenges faced by the continent. The Institute is about research and healthcare for all Africans by Africans. PACRI is distinguished by meeting rigorous standards for transdisciplinary, state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer and advancing precision/personalised oncology in the region. In the spirit of “Defeating Cancer Together”, PACRI has a strong drive in collaborative transdisciplinary research that addresses cancer health disparities and its impact on underserved and socio-economically disadvantaged populations.

Translational Oncology Research
Pretoria, South Africa
Translational OncologyTranslational ResearchCancer PreventionCancer ControlCancer EducationAfrica
Website
Company

PamDx

At PamDx we are dedicated to support physicians and scientists in finding solutions and answers to improve and optimize patient treatment and understand diseases. Our multiplex kinase activity profiling technology reveals the bigger picture of cellular signaling and provides mechanistic insights needed to fully understand diseases and cell alterations.

Kinase activity profiling for Oncology R&D and diagnostics
Hertogenbosch, Netherlands
Precision OncologyScreeningKinasesKinomeMolecular & Cell BiologyTranslational OncologyDiagnostics
Website
Hospital

Parkway Cancer Centre

Singapore, Singapore
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Peking University People's Hospital

Chinese university hospital that hosts the Peking University Institute of Hematology, a major transplant centre.

University Hospital
Beijing, China
HematologyBlood CancersStem Cell TransplantationLeukemiaClinical Research
Website
Company

Persea Pharma

Persea is developping BioTrojan, a cellular Trojan Horse delivered locally for a powerfull local impact.

Targeted gene therapy for treatment of solid tumors
Suresnes, France
Cancer TherapeuticsGene TherapySuicide GeneCellular DeliveryTargeted DeliverySolid Tumors
Website
Hospital

Peter MacCallum Cancer Centre

Peter Mac is a Comprehensive Cancer Centre, delivering integrated treatment, research and education and leading the way in cancer care across Australia

Cancer Care & Research
Melbourne, VIC, Australia
Cancer CareCancer ResearchClinical TrialsClinical OncologyPatient CareTranslational OncologyRadiation Oncology
Website
Professional Association

PETHEMA (Programa Español de Tratamientos en Hematología)

In Spanish: "PETHEMA es un grupo cooperativo de médicos especialistas y otros profesionales sanitarios de diversa índole que trabajan coordinadamente para el desarrollo de investigación de la máxima calidad científica en Medicina, concretamente en el campo de la Hematología (especialidad que se centra en el estudio de la sangre, la médula ósea y los órganos linfáticos). PETHEMA, cuyas siglas responden a “Programa Español de Tratamientos en Hematología”, es un grupo de investigación de naturaleza académica e independiente, que pertenece a la Sociedad Española de Hematología y Hemoterapia (SEHH). La SEHH que es la sociedad científica que aglutina la defensa central e integrada de todos los intereses relacionados con la especialidad de Hematología y Hemoterapia y que busca por encima de todo el máximo nivel de excelencia en el ejercicio de la medicina hematológica."

Hematology
Madrid, Spain
HematologyHemato-OncologyBlood CancersClinical TrialsClinical ResearchBasic ResearchEpidemiology
Website